ArticleFrontiers in oncology2022

Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITD.

Marie Schwarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.